Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

Miaomiao Wen,1 Jinghua Xia,1 Ying Sun,1 Xuejiao Wang,1 Xianghui Fu,2 Yanning Zhang,1 Zhipei Zhang,1 Yongan Zhou,1 Xiaofei Li1 1Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an 710038, Shaanxi, China; 2Department of Clinical Immunology, Xijing H...

Full description

Bibliographic Details
Main Authors: Wen M, Xia J, Sun Y, Wang X, Fu X, Zhang Y, Zhang Z, Zhou Y, Li X
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Biologics: Targets & Therapy
Subjects:
non-small cell lung cancer
epidermal growth factor receptor-tyrosine kinase inhibitor
chemotherapy
adjuvant therapy
retrospective study
Online Access:https://www.dovepress.com/combination-of-egfr-tkis-with-chemotherapy-versus-chemotherapy-or-egfr-peer-reviewed-article-BTT

Internet

https://www.dovepress.com/combination-of-egfr-tkis-with-chemotherapy-versus-chemotherapy-or-egfr-peer-reviewed-article-BTT

Similar Items